Business Description
SomnoMed Ltd
SIC : 3840
ISIN : AU000000SOM1
Description
SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.41 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | -2.56 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.14 | |||||
| Beneish M-Score | -2.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.6 | |||||
| 3-Year EPS without NRI Growth Rate | -116.2 | |||||
| 3-Year FCF Growth Rate | -95.4 | |||||
| 3-Year Book Growth Rate | -11.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 10.69 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.73 | |||||
| 9-Day RSI | 58.71 | |||||
| 14-Day RSI | 59.85 | |||||
| 6-1 Month Momentum % | 2 | |||||
| 12-1 Month Momentum % | -29.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.76 | |||||
| Quick Ratio | 1.45 | |||||
| Cash Ratio | 0.81 | |||||
| Days Inventory | 50.68 | |||||
| Days Sales Outstanding | 34.98 | |||||
| Days Payable | 121.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -25.9 | |||||
| Shareholder Yield % | -27.04 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.15 | |||||
| Operating Margin % | -9.09 | |||||
| Net Margin % | -13.36 | |||||
| FCF Margin % | -12.74 | |||||
| ROE % | -37.73 | |||||
| ROA % | -18.72 | |||||
| ROIC % | -22.2 | |||||
| ROC (Joel Greenblatt) % | -64.37 | |||||
| ROCE % | -17.95 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 460 | |||||
| PS Ratio | 0.61 | |||||
| PB Ratio | 2.17 | |||||
| Price-to-Tangible-Book | 3.83 | |||||
| EV-to-EBIT | -10.7 | |||||
| EV-to-EBITDA | -34.23 | |||||
| EV-to-Revenue | 0.99 | |||||
| EV-to-FCF | -7.89 | |||||
| Price-to-Median-PS-Value | 0.24 | |||||
| Price-to-Net-Current-Asset-Value | 9.2 | |||||
| Earnings Yield (Greenblatt) % | -9.34 | |||||
| FCF Yield % | -11.74 | |||||
| Forward Rate of Return (Yacktman) % | 7.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SomnoMed Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 91.652 | ||
| EPS (TTM) (A$) | -0.102 | ||
| Beta | 1.54 | ||
| Volatility % | 83.42 | ||
| 14-Day RSI | 59.85 | ||
| 14-Day ATR (A$) | 0.025451 | ||
| 20-Day SMA (A$) | 0.4445 | ||
| 12-1 Month Momentum % | -29.14 | ||
| 52-Week Range (A$) | 0.19 - 0.505 | ||
| Shares Outstanding (Mil) | 216.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SomnoMed Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SomnoMed Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
SomnoMed Ltd Frequently Asked Questions
What is SomnoMed Ltd(ASX:SOM)'s stock price today?
The current price of ASX:SOM is A$0.46. The 52 week high of ASX:SOM is A$0.51 and 52 week low is A$0.19.
When is next earnings date of SomnoMed Ltd(ASX:SOM)?
The next earnings date of SomnoMed Ltd(ASX:SOM) is .
Does SomnoMed Ltd(ASX:SOM) pay dividends? If so, how much?
SomnoMed Ltd(ASX:SOM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers